Detalles de la búsqueda
1.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci;
44(1): 281-286, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166174
2.
Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
Mult Scler;
26(8): 945-954, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124748
3.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci;
41(11): 3369-3371, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918634
4.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci;
41(11): 3329-3335, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840711
5.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci;
41(6): 1513-1519, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960250
6.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci;
42(12): 5441, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34557969
7.
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Clin Neuropharmacol;
2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776535
8.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
J Neurol Sci;
461: 123052, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797140
9.
Shared decision making in the treatment of multiple sclerosis: A consensus based on Delphi methodology.
Mult Scler Relat Disord;
70: 104465, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565557
10.
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Mult Scler J Exp Transl Clin;
9(1): 20552173231154712, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36846108
11.
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Mult Scler Relat Disord;
79: 104935, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634468
12.
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Mult Scler J Exp Transl Clin;
9(4): 20552173231205444, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854639
13.
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEM.
Neurol Res;
45(2): 112-117, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36184106
14.
Rebound activity after fingolimod cessation: A case - control study.
Mult Scler Relat Disord;
57: 103329, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158443
15.
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina.
Mult Scler Relat Disord;
58: 103483, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032883
16.
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM.
J Neurol;
269(4): 2073-2079, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34491406
17.
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.
Mult Scler Relat Disord;
58: 103466, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34929456
18.
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Mult Scler Relat Disord;
68: 104104, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057175
19.
An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
Front Immunol;
12: 628024, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33717149
20.
Usage trend of oral drugs for multiple sclerosis patients in Argentina.
Mult Scler Relat Disord;
47: 102664, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33291031